Ani Pharmaceuticals (ANIP) Depreciation & Amortization - Total (2012 - 2020)

Ani Pharmaceuticals has disclosed Depreciation & Amortization - Total across 9 years of filings, most recently posting $1.3 million for Q4 2020.

• In Q4 2020, Depreciation & Amortization - Total rose 8.33% year-over-year to $1.3 million; the TTM figure through Dec 2020 stood at $4.9 million (up 6.52% YoY), while the FY2025 annual figure was $8.9 million, up 20.27% from the prior year.
• Depreciation & Amortization - Total came in at $1.3 million for Q4 2020 at Ani Pharmaceuticals, up from $1.2 million in the prior quarter.
• In the past five years, Depreciation & Amortization - Total ranged from a high of $1.3 million in Q4 2020 to a low of $200000.0 in Q1 2016.
• Average Depreciation & Amortization - Total over 5 years is $680000.0, with a median of $500000.0 recorded in 2018.
• Year-over-year, Depreciation & Amortization - Total changed 0.0% in 2016 and surged 300.0% in 2019.
• Over 5 years, Depreciation & Amortization - Total stood at $200000.0 in 2016, then surged by 50.0% to $300000.0 in 2017, then soared by 166.67% to $800000.0 in 2018, then surged by 50.0% to $1.2 million in 2019, then gained by 8.33% to $1.3 million in 2020.
• Per Business Quant data, the three most recent Depreciation & Amortization - Total figures were $1.3 million in Q4 2020, $1.2 million in Q3 2020, and $1.2 million in Q2 2020.